Prescription Drug Spending: What’s Coming Next for Medicaid and How Can States Prepare?
Experts at the NAMD Fall Conference discussed challenges with high-cost drugs.
NAMD Board of Directors names association’s next executive director
Unwinding the Public Health Emergency’s Continuous Coverage Requirement Partner Webinar
Medicaid directors in California, Iowa, and North Carolina talk about the upcoming unwinding of the public health emergency's continuous coverage...
Medicaid Forward: Long-Term Services and Supports
Medicaid Forward: Long-term Services and Supports focuses on four immediate opportunities to shift long-term care, in a report and webinar.
Waivers
Waivers are an essential part of the strategy many states use to ensure their programs are meeting the needs of their individual populations. Programs across the country use federally-approved waivers to meet a host of goals including coverage expansion, cost containment or improved care for specific groups such as individuals living with disabilities or pregnant women.
What’s Their Why: Reflections from Medicaid Directors
In this video, Medicaid Directors from all over the country discuss why they do this work.
2021 Spotlight Award for Innovation: Florida
The Spotlight Award recognizes the spectacular work Medicaid agencies have done in service to the 80 million people covered by...
NAMD Urges CMS to Mitigate State Costs on Controversial Alzheimer’s Drug
In formal comments, NAMD calls on Medicare to step up and cover the Alzheimer’s drug Aduhelm. Failure to do so...
Medicare Must Not Cost Shift Alzheimer’s Care to Medicaid
NAMD explains the serious cost implications of Medicare’s coverage decision on the Alzheimer’s drug Aduhelm for state Medicaid programs.